The 'Expiry Problem' of broad consent for biobank research - And why a meta consent model solves it.

genetic information informed consent research ethics

Journal

Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619

Informations de publication

Date de publication:
09 2020
Historique:
received: 31 01 2020
accepted: 10 02 2020
pubmed: 27 2 2020
medline: 18 9 2021
entrez: 27 2 2020
Statut: ppublish

Résumé

In this response to Neil Manson's latest intervention in our debate about the best consent model for biobank research we show, contra Manson that the 'expiry problem' that affects broad consent models because of changes over time in methods, purposes, types of data used and governance structures is a real and significant problem. We further show that our preferred implementation of meta consent as a national consent platform solves this problem and is not subject to the cost and burden objections that Manson raises.

Identifiants

pubmed: 32098907
pii: medethics-2020-106117
doi: 10.1136/medethics-2020-106117
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

629-631

Commentaires et corrections

Type : CommentOn

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Thomas Ploug (T)

Centre for Applied Ethics and Philosophy of Science, Department of Communication and Psychology, Aalborg University Copenhagen, København S, Denmark ploug@hum.aau.dk.

Søren Holm (S)

Centre for Social Ethics and Policy, School of Law, University of Manchester, Manchester, UK.
Center of Medical Ethics, Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH